AstraZeneca Q2 Earnings Beat Forecasts as Oncology Growth Supports 2026 Outlook 
Nvidia Eyes $250B Guarantee for OpenAI’s Massive Ohio AI Data Center Project 
Air Liquide Q2 Sales Growth Tops Forecast as Electronics Business Drives Strong Performance 
BHP, Port Hedland Unions Fail to Reach Wage Deal as Negotiations Continue 
Serica Energy to Acquire Pharos Energy for £145.7M, Sending PHARP Shares Soaring 
Seagate Stock Jumps as AI-Fueled Earnings Beat and Strong FY2027 Outlook Impress Investors 
Standard Chartered Beats Profit Forecasts as First-Half Earnings Rise 9% 
Galp Shares Fall After Q2 EBITDA Miss Despite Profit Beat and Higher Dividend 
CATL Shares Jump as $5.6 Billion Buyback Signals Confidence in Long-Term Growth 
Brown-Forman Rejects Sazerac’s $15 Billion Takeover Bid as Family Backs Independence 
Nvidia Invests $1 Billion in Naver as South Korea AI Data Center Expansion Gains Momentum 
Zabka Shares Drop 10% as Seven & i Abandons Investment Plans 
ASML, Applied Materials Slide as China DUV Chip Equipment Breakthrough Sparks Market Jitters 
Meta CEO Zuckerberg Opposes U.S. Ban on Chinese AI Models, Warns Against Overregulation 
SK Hynix Q2 Profit Hits Record as AI Memory Chip Demand Fuels Growth 
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline 
The US Justice Department sued Walmart over its role in the opioid crisis, alleging irresponsible handling of orders, wrongly filling thousands of prescriptions, and ignoring warning signs about problem orders to boost sales.
Up to billions of dollars in penalties could be sought in the litigation that followed a multi-year investigation.
According to Jeffrey Bossert Clark, acting head of the Justice Department's civil division, Walmart had the responsibility and the means to help prevent the diversion of prescription opioids but instead did the opposite by filling thousands of invalid prescriptions and failing to report suspicious opioid orders.
The government lawsuit said Walmart managers enormously pressured pharmacists to fill prescriptions and that it withheld the information from pharmacists on data on invalid controlled-substance prescriptions.
Walmart claimed the charges were baseless and accused US authorities of shifting blame from the Drug Enforcement Administration's failures in keeping bad doctors from prescribing opioids. It added that the complaint was "riddled with factual inaccuracies."
According to the Centers for Disease Control and Prevention, nearly 450,000 Americans died between 1999 and 2018 from overdoses due to prescription and illegal opioids.
